vs
Kiniksa Pharmaceuticals International, plc（KNSA）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Kiniksa Pharmaceuticals International, plc的1.0倍（$212.2M vs $202.1M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 7.0%，领先11.8%），Kiniksa Pharmaceuticals International, plc同比增速更快（65.0% vs 8.6%），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs 11.1%）
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
KNSA vs RAMP — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $212.2M |
| 净利润 | $14.2M | $39.9M |
| 毛利率 | 89.6% | 71.9% |
| 营业利润率 | 9.8% | 18.6% |
| 净利率 | 7.0% | 18.8% |
| 营收同比 | 65.0% | 8.6% |
| 净利润同比 | 259.8% | 255.7% |
| 每股收益（稀释后） | $0.18 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $202.1M | $212.2M | ||
| Q3 25 | $180.9M | $199.8M | ||
| Q2 25 | $156.8M | $194.8M | ||
| Q1 25 | $137.8M | $188.7M | ||
| Q4 24 | $122.5M | $195.4M | ||
| Q3 24 | $112.2M | $185.5M | ||
| Q2 24 | $108.6M | $176.0M | ||
| Q1 24 | $79.9M | $171.9M |
| Q4 25 | $14.2M | $39.9M | ||
| Q3 25 | $18.4M | $27.4M | ||
| Q2 25 | $17.8M | $7.7M | ||
| Q1 25 | $8.5M | $-6.3M | ||
| Q4 24 | $-8.9M | $11.2M | ||
| Q3 24 | $-12.7M | $1.7M | ||
| Q2 24 | $-3.9M | $-7.5M | ||
| Q1 24 | $-17.7M | $-5.4M |
| Q4 25 | 89.6% | 71.9% | ||
| Q3 25 | 88.8% | 70.2% | ||
| Q2 25 | 88.1% | 70.1% | ||
| Q1 25 | 87.0% | 69.3% | ||
| Q4 24 | 85.4% | 71.9% | ||
| Q3 24 | 82.1% | 72.4% | ||
| Q2 24 | 88.7% | 70.6% | ||
| Q1 24 | 86.7% | 72.2% |
| Q4 25 | 9.8% | 18.6% | ||
| Q3 25 | 13.3% | 10.7% | ||
| Q2 25 | 12.9% | 3.7% | ||
| Q1 25 | 9.6% | -6.1% | ||
| Q4 24 | -15.7% | 7.5% | ||
| Q3 24 | -8.6% | 4.0% | ||
| Q2 24 | -0.1% | -3.0% | ||
| Q1 24 | -20.7% | -8.3% |
| Q4 25 | 7.0% | 18.8% | ||
| Q3 25 | 10.2% | 13.7% | ||
| Q2 25 | 11.4% | 4.0% | ||
| Q1 25 | 6.2% | -3.3% | ||
| Q4 24 | -7.3% | 5.7% | ||
| Q3 24 | -11.3% | 0.9% | ||
| Q2 24 | -3.6% | -4.3% | ||
| Q1 24 | -22.2% | -3.1% |
| Q4 25 | $0.18 | $0.62 | ||
| Q3 25 | $0.23 | $0.42 | ||
| Q2 25 | $0.23 | $0.12 | ||
| Q1 25 | $0.11 | $-0.10 | ||
| Q4 24 | $-0.11 | $0.17 | ||
| Q3 24 | $-0.18 | $0.03 | ||
| Q2 24 | $-0.06 | $-0.11 | ||
| Q1 24 | $-0.25 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $414.1M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $567.6M | $962.3M |
| 总资产 | $763.6M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $414.1M | $403.4M | ||
| Q3 25 | $352.1M | $376.9M | ||
| Q2 25 | $307.8M | $371.1M | ||
| Q1 25 | $268.3M | $420.8M | ||
| Q4 24 | $243.6M | $384.3M | ||
| Q3 24 | $223.8M | $348.4M | ||
| Q2 24 | $218.8M | $342.7M | ||
| Q1 24 | $213.6M | $368.9M |
| Q4 25 | $567.6M | $962.3M | ||
| Q3 25 | $535.4M | $943.8M | ||
| Q2 25 | $495.0M | $947.8M | ||
| Q1 25 | $457.5M | $948.9M | ||
| Q4 24 | $438.4M | $957.7M | ||
| Q3 24 | $437.0M | $932.1M | ||
| Q2 24 | $435.1M | $951.9M | ||
| Q1 24 | $431.9M | $949.1M |
| Q4 25 | $763.6M | $1.3B | ||
| Q3 25 | $712.3M | $1.2B | ||
| Q2 25 | $661.1M | $1.2B | ||
| Q1 25 | $599.3M | $1.3B | ||
| Q4 24 | $580.6M | $1.3B | ||
| Q3 24 | $555.3M | $1.2B | ||
| Q2 24 | $542.4M | $1.2B | ||
| Q1 24 | $519.7M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.9M | — |
| 自由现金流经营现金流 - 资本支出 | $53.3M | — |
| 自由现金流率自由现金流/营收 | 26.4% | — |
| 资本支出强度资本支出/营收 | 0.3% | 0.1% |
| 现金转化率经营现金流/净利润 | 3.80× | — |
| 过去12个月自由现金流最近4个季度 | $136.4M | — |
8季度趋势，按日历期对齐
| Q4 25 | $53.9M | — | ||
| Q3 25 | $33.7M | $57.4M | ||
| Q2 25 | $28.1M | $-15.8M | ||
| Q1 25 | $22.3M | — | ||
| Q4 24 | $18.8M | $45.1M | ||
| Q3 24 | $-2.2M | $55.6M | ||
| Q2 24 | $5.2M | $-9.3M | ||
| Q1 24 | $4.0M | — |
| Q4 25 | $53.3M | — | ||
| Q3 25 | $33.0M | $56.8M | ||
| Q2 25 | $27.9M | $-16.2M | ||
| Q1 25 | $22.2M | — | ||
| Q4 24 | $18.6M | $44.8M | ||
| Q3 24 | — | $55.4M | ||
| Q2 24 | — | $-9.6M | ||
| Q1 24 | $3.9M | — |
| Q4 25 | 26.4% | — | ||
| Q3 25 | 18.2% | 28.4% | ||
| Q2 25 | 17.8% | -8.3% | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 15.2% | 22.9% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | 4.9% | — |
| Q4 25 | 0.3% | 0.1% | ||
| Q3 25 | 0.4% | 0.3% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.1% | 1.0% |
| Q4 25 | 3.80× | — | ||
| Q3 25 | 1.83× | 2.09× | ||
| Q2 25 | 1.58× | -2.04× | ||
| Q1 25 | 2.61× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
